Arcturus Therapeutics Holdings Inc.

ARCT · Nasdaq · SIC 2834: Pharmaceutical Preparations
150
SEC Filings

Business Summary

PART I Overview We are a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics. We have ongoing Phase 2 clinical studies for our RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF). We developed the worlds first approved self-amplifying messenger RNA (sa-mRNA) vaccine, KOSTAIVE (KOSTAIVE), which we have partnered with Seqirus, Inc. (CSL Seqirus), a part of CSL Limited. KOSTAIV...

Next Earnings

Q2 FY2026 — expected 2026-09-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionARCTdiscussed_in_filing Cybersecurity
topic_mentionARCTdiscussed_in_filing Cybersecurity
topic_mentionARCTdiscussed_in_filing Blockchain & Crypto
topic_mentionARCTdiscussed_in_filing Healthcare & Bio
topic_mentionARCTdiscussed_in_filing Blockchain & Crypto
topic_mentionARCTdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-032025-12-310001193125-26-088391EDGAR70K words
2025-03-062024-12-310000950170-25-034787EDGAR—
2024-03-142023-12-310000950170-24-031156EDGAR—
2023-03-292022-12-310000950170-23-010380EDGAR—
2022-03-012021-12-310001564590-22-007832EDGAR—
2021-03-012020-12-310001564590-21-009872EDGAR—
2020-03-162019-12-310001564590-20-011037EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-275758EDGAR23K words
2025-08-112025-06-300000950170-25-106560EDGAR—
2025-05-122025-03-310000950170-25-069210EDGAR—
2024-11-072024-09-300000950170-24-123469EDGAR—
2024-08-052024-06-300000950170-24-090905EDGAR—
2024-05-082024-03-310000950170-24-055702EDGAR—
2023-11-142023-09-300000950170-23-063778EDGAR—
2023-08-072023-06-300000950170-23-039149EDGAR—
2023-05-092023-03-310000950170-23-019773EDGAR—
2022-11-092022-09-300000950170-22-023969EDGAR—
2022-08-092022-06-300000950170-22-016043EDGAR—
2022-05-092022-03-310000950170-22-008524EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-030001193805-26-000214EDGAR3K words
2025-12-150001193805-25-001734EDGAR—
2025-11-100001193805-25-001555EDGAR—
2025-10-220001193805-25-001499EDGAR—
2025-09-260001193805-25-001368EDGAR—
2025-08-290001193805-25-001247EDGAR—
2025-08-110001193805-25-001175EDGAR—
2025-06-300001193805-25-000946EDGAR—
2025-06-060001193805-25-000820EDGAR—
2025-05-120001193805-25-000630EDGAR—

150 total filings indexed. 121 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001768224
TickerARCT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b446d6b76e323e386b8851502879ce092f26891c2eefd205a09f2de1e3dad611
parent: ddf1a88d2a6d1c16652000aae845b3287aa19d46ce88a7f6b76825ff29842719
content hash: ede4d394a2bf219515c358d30eaac33f2db2106e1fc632ba20f1432a1c92ebbc
signed: 2026-04-13T04:43:42.881Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf